Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $37.41, giving the company a market capitalization of 3.93B. It carries a P/E multiple of 40.38.
During the trading session on 2026-02-24, Corcept Therapeutics(CORT) shares reached a daily high of $37.58 and a low of $33.80. At a current price of $37.41, the stock is +10.7% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 675.95K, compared to an average daily volume of 2.2M.
The stock's 52-week range extends from a low of $28.66 to a high of $117.33.
The stock's 52-week range extends from a low of $28.66 to a high of $117.33.
CORT News
If you are wondering whether Corcept Therapeutics at around US$34.82 is starting to look interesting on price, you are not alone. The stock has been drawing att...
H.C. Wainwright lowered the firm’s price target on Corcept Therapeutics (CORT) to $67 from $105 and keeps a Buy rating on the shares. The U.S. Court of Appeals...
Corcept Therapeutics ( (CORT) ) just unveiled an update. On February 19, 2026, Corcept Therapeutics announced that the U.S. Court of Appeals for the Federal Ci...
Analyst ratings
71%
of 7 ratingsMore CORT News
Corcept Therapeutics Incorporated (CORT) announced that the United States Court of Appeals for the Federal Circuit has found that Teva Pharmaceuticals’ (TEVA) m...
Corcept Therapeutics shares are approaching critical lows. What’s pressuring CORT? Appeals Court Upholds Ruling Against Corcept Corcept had argued that Teva's l...
Biopharma firm Corcept Therapeutics’ (CORT) shares took a massive beating on Thursday morning. This came after a U.S. appeals court affirmed an earlier non-infr...
In late December 2025, Corcept Therapeutics received a Complete Response Letter from the U.S. FDA for its relacorilant NDA in hypertension secondary to hypercor...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.